What's New
- Ancillary Utilization Plans and the Administration of Drugs and Devices Guidance Document Revised (PDF)
- New Inspection Areas - see our recent announcement
- Guidance on Electronic Prescriptions and Cyberattacks
- COVID-19 Vaccine Guidance from DOH
- Emergent Drug Shortages – The Pharmacy Commission is aware of several drug shortages that have had a deleterious impact on patient care, including shortages affecting certain chemotherapy drugs. See this statement from the commission about the shortages.
- Guidance on Mifepristone from the Pharmacy Commission
- Updated Nonresident Pharmacy Directive on Approved Inspection Programs (PDF) - Effective immediately, nonresident pharmacy applicants need to meet the requirements specified in this directive. Nonresident pharmacies that are currently licensed must meet the requirements specified in this directive for the May 2024 renewal.
Helpful Contact Information
| Review Team 2 | Pharmacy intern, pharmacists, pharmacy technicians | Email: hsqareview2@doh.wa.gov Phone: 360-236-4986 |
| Facilities Team | All pharmaceutical firms, ancillary utilization plans (AUP), technician training programs (TTP), collaborative drug therapy agreements (CTDA), and change of responsible pharmacist manager forms. | Email: hsqafc@doh.wa.gov Phone: 360-236-4985 |